Report period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, CN¥ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
2269:HK | WuXi Biologics | Common share | - | KYG970081173 | HK$21.15 |
Company name | WuXi Biologics |
---|---|
Tags | #hong_kong_spb, #biotechnology |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
Business address | No. 108, Meiliang Road Mashan Binhu District Wuxi 214092 China |
Mailing address | No. 108, Meiliang Road Mashan Binhu District Wuxi 214092 China |
Website | www.wuxibiologics.com |